Things are so clownish now, that if at first you don't succeed try again, the masses won't do much of anything.
A Government laboratory in Maryland plans to make the circulating monkeypox strain more lethal in highly controversial research in mice.
The team wants to equip the dominant clade - which mostly causes a rash and flu-like symptoms - with genes from another strain that causes severe disease.
It comes just a week after DailyMail.com revealed a similar experiment involving a hybrid Covid strain was conducted at Boston University.
The latest monkeypox study is being funded by the National Institute of Allergy and Infectious Diseases (NIAID), a research arm of National Institutes of Health (NIH).
The team in Maryland would argue their work does not involve 'enhancing' a pathogen because they are swapping natural mutations rather than creating new ones, meaning the hybrid cannot be more deadly than the existing clades.
But the news will no doubt surprise many Americans that such research continues to go on in the US despite fears similar practices may have started the pandemic.
The Maryland experiment was exempt from oversight when it was given the green light in 2018 because monkeypox did not meet the threshold for a 'potential pandemic pathogen'.
Lab in Maryland plans to develop more severe monkeypox strain
The team in Bethesda want to equip the dominant clade - which mostly causes a rash and flu-like symptoms - with genes from another strain that causes severe disease.
www.dailymail.co.uk
A Government laboratory in Maryland plans to make the circulating monkeypox strain more lethal in highly controversial research in mice.
The team wants to equip the dominant clade - which mostly causes a rash and flu-like symptoms - with genes from another strain that causes severe disease.
It comes just a week after DailyMail.com revealed a similar experiment involving a hybrid Covid strain was conducted at Boston University.
The latest monkeypox study is being funded by the National Institute of Allergy and Infectious Diseases (NIAID), a research arm of National Institutes of Health (NIH).
The team in Maryland would argue their work does not involve 'enhancing' a pathogen because they are swapping natural mutations rather than creating new ones, meaning the hybrid cannot be more deadly than the existing clades.
But the news will no doubt surprise many Americans that such research continues to go on in the US despite fears similar practices may have started the pandemic.
The Maryland experiment was exempt from oversight when it was given the green light in 2018 because monkeypox did not meet the threshold for a 'potential pandemic pathogen'.
Last edited: